Skip to main content
. Author manuscript; available in PMC: 2009 Dec 4.
Published in final edited form as: Bioconjug Chem. 2009 Jan;20(1):147–154. doi: 10.1021/bc8003765

Figure 8.

Figure 8

Change in background fluorescence intensities after A; avidin or Av-QSY21, B; neutravidin or nAv-QSY21 or C; streptavidin or sAv-QSY21 treatments. *P < 0.05 (Mann-Whitney U-test) vs. non-treated control. 129×188mm (300 × 300 DPI)